Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Corticosteroids and bioavailability.

S S Stubbs

    Transplantation Proceedings
    |March 1, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Physicians prescribing corticosteroids must understand bioavailability and bioequivalence. In vitro tests are unreliable for predicting formulation variability; bioavailability studies are essential for ensuring product equivalence and safety.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Pharmacokinetic interpretation of plasma cortisol and cortisone concentrations following a signle oral administration of cortisone acetate to human subjects.

    Journal of clinical pharmacology·1980
    Same author

    The clinical pharmacology of methylprednisolone sodium phosphate. II. Intravenous route of administration.

    Toxicology and applied pharmacology·1977
    Same author

    The clinical pharmacology of methylprednisolone sodium phosphate. I. Intramuscular route of administration.

    Journal of clinical pharmacology·1977
    Same author

    Anorectal pruritus after intravenous hydrocortisone sodium succinate and sodium phosphate.

    Clinical pharmacology and therapeutics·1976
    Same author

    In vitro effect of methylprednisolone on protein synthesis of activated canine thymus-derived lymphocytes.

    Transplantation proceedings·1975
    Same author

    Intravenous methylprednisolone sodium succinate: adverse reactions reported in association with immunosuppresive therapy.

    Transplantation proceedings·1973

    Area of Science:

    • Pharmacology
    • Pharmaceutical Sciences

    Background:

    • Corticosteroids are widely prescribed, necessitating an understanding of formulation differences.
    • Physicians rely on the clinical efficacy and safety of corticosteroid formulations.

    Purpose of the Study:

    • To highlight the critical importance of bioavailability and bioequivalence for corticosteroid formulations.
    • To emphasize the limitations of in vitro testing in predicting in vivo performance.

    Main Methods:

    • Review of existing data and principles related to drug formulation and performance.
    • Discussion of the role of bioavailability studies in pharmaceutical development.

    Main Results:

    • In vitro tests may not accurately predict the variability between different corticosteroid formulations.

    Related Experiment Videos

  • Bioavailability studies are crucial for establishing bioequivalence between generic and innovator products.
  • Bioavailability methodology serves as a valuable pharmacological tool.

    • Conclusions:

    • Manufacturers must conduct bioavailability studies to prove bioequivalence, not just rely on in vitro tests.
    • Physicians should be aware of the bioavailability data of the corticosteroid products they prescribe.
    • Understanding bioavailability is key to ensuring therapeutic equivalence and patient safety.